{
  "retracted": false,
  "timestamp": 1496275200000,
  "updates": [
    {
      "timestamp": 1578091305888,
      "identifier": {
        "doi": "10.1016/j.pharep.2017.01.018"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.pharep.2015.07.002"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Corrigendum to “Oral treatment with enrofloxacin early in life promotes Th2-mediated immune response in mice” [Pharmacol. Rep. 68 (2016) 44–50]"
}
